The Cochrane Breast Cancer Group is committed to the development of evidence relating to the prevention, early detection, treatment and follow-up care of breast cancer. The Group as registered as a Collaborative Review Group with the Cochrane Collaboration in September 1996.

Our activities are coordinated by an international team of editors and an editorial base located at the NHMRC Clinical Trials Centre, The University of Sydney, Australia.

The Cochrane Breast Cancer Group would like to acknowledge its current funders:
(a) National Health and Medical Research Council (NHMRC), Australia
(b) National Breast Cancer Foundation (NBCF), Australia